Skip to content

Clinical trials

Hepatitis D trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis D Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20091
20112
20131
20141
20153
20163
20171
20183
20191
20215
20225
20236
20249
20259
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting13
Unknown status10
Active, not recruiting8
Not yet recruiting5
Terminated3
No longer available1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)7
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico4
Vir Biotechnology, Inc.4
Eiger BioPharmaceuticals3
Mirum Pharmaceuticals, Inc.3
Hannover Medical School2
HepNet Study House, German Liverfoundation2
National Taiwan University Hospital2
University of Alabama at Birmingham2
Aga Khan University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis D59
Hepatitis B16
Hepatitis D, Chronic10
Hepatitis7
Hepatitis B, Chronic6
Liver Cirrhosis6
Liver Diseases6
Fibrosis5
Hepatitis C5
Carcinoma, Hepatocellular4

Trials

Showing 76 to 59 of 59. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.